Marker Therapeutics corrects option grant date to Feb 12, 2025; awards options to CEO and directors

Marker Therapeutics, Inc.

CEO Dr. Juan Vera receives 50,000 stock options vesting annually over three years.
Non-employee directors David Eansor, Katherine Knobil, Steven Elms each receive 30,000 options.
Amendment corrects prior filing: grant date changed from Feb 12, 2024 to Feb 12, 2025.
All options are under the 2020 Omnibus Stock Ownership Plan and standard award agreement.

item 5.02 item 8.01 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001104659-25-020405
form_type: 8-K/A
ticker: MRKR
cik: 0001094038
company_name: Marker Therapeutics, Inc.
filed_at: 2025-03-04T23:59:59+00:00
discovered_at: 2026-05-14T18:03:02.912377+00:00
generated_at: 2026-05-25T12:40:16.896168+00:00
sec_items: ["5.02", "8.01", "9.01"]
event_type: other_material
sentiment: neutral
materiality_score: 0.25
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001104659-25-020405
json_url: https://secwatch.observer/filing/0001104659-25-020405.json
markdown_url: https://secwatch.observer/filing/0001104659-25-020405.md
text_url: https://secwatch.observer/filing/0001104659-25-020405.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1094038/000110465925020405/0001104659-25-020405-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1094038/000110465925020405/tm258250d1_8ka.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source: SEC EDGAR

accession 0001104659-25-020405

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.